Back to MOORE CAPITAL MANAGEMENT, LP MOORE CAPITAL MANAGEMENT, LP

CRNXCRNX
2 quarters

Position history for MOORE CAPITAL MANAGEMENT, LPMOORE CAPITAL MANAGEMENT, LP's holdings in CRINETICS PHARMACEUTICALS IN

MOORE CAPITAL MANAGEMENT, LP previously held 0 shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$308,448

Total Shares Change

-17,117

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$29.74
0
2023-Q2
New
17,117
-
$308,4480.0%$17.81
32

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used